Platelet aggregation: methodology and physiopathology.
The physiopathological role of platelet aggregation in some thromboembolic and atherosclerotic complications is strongly suggested on the basis of many indirect findings. The qualitative methodological approach to this problem generally used until recently is rapidly giving way to a quantitative, biochemical approach. Platelet aggregation, however, even if expressed in terms of nanomoles of a product obtained in a sophisticated reaction system, will continue to deceive investigators and clinicians who fail to view it in the adequate (although still uncertain) context of rheological and vascular interactions.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001161:Arteriosclerosis / Q000097:blood* / Q000503:physiopathology; D011464:Epoprostenol / Q000378:metabolism; D006487:Hemostasis; D006801:Humans; D010974:Platelet Aggregation; D011449:Prostaglandin Endoperoxides / Q000378:metabolism; D013927:Thrombosis / Q000097:blood* / Q000503:physiopathology
D001095:Arachidonic Acids; D011449:Prostaglandin Endoperoxides; D011464:Epoprostenol